Xiaoli Xie

462 total citations
19 papers, 329 citations indexed

About

Xiaoli Xie is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Xiaoli Xie has authored 19 papers receiving a total of 329 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 6 papers in Oncology and 6 papers in Immunology. Recurrent topics in Xiaoli Xie's work include Cancer Immunotherapy and Biomarkers (4 papers), Cancer-related molecular mechanisms research (4 papers) and RNA modifications and cancer (3 papers). Xiaoli Xie is often cited by papers focused on Cancer Immunotherapy and Biomarkers (4 papers), Cancer-related molecular mechanisms research (4 papers) and RNA modifications and cancer (3 papers). Xiaoli Xie collaborates with scholars based in China, United States and Taiwan. Xiaoli Xie's co-authors include Lijuan Wang, Fengyuan Che, Jiawei Yin, Yufu Ye, Yujing Wang, Yan Gao, Shuying Chen, Yanchun Quan, Yifeng Du and Sheng Xia and has published in prestigious journals such as Gastroenterology, Atherosclerosis and Oncotarget.

In The Last Decade

Xiaoli Xie

17 papers receiving 325 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Xiaoli Xie China	9	188	106	81	58	30	19	329
Da Qian China	9	166 0.9×	168 1.6×	73 0.9×	78 1.3×	42 1.4×	36	366
Jamie A Moore United Kingdom	8	171 0.9×	79 0.7×	36 0.4×	72 1.2×	37 1.2×	16	308
Xiaojie Gan China	12	143 0.8×	99 0.9×	64 0.8×	87 1.5×	24 0.8×	23	334
Yelitza A. R. Rodriguez United States	7	153 0.8×	64 0.6×	66 0.8×	63 1.1×	8 0.3×	8	320
Tammy L. Palenski United States	10	173 0.9×	34 0.3×	73 0.9×	39 0.7×	52 1.7×	20	385
Omid Omrani Germany	8	151 0.8×	36 0.3×	52 0.6×	21 0.4×	28 0.9×	19	272
Núria Palau Spain	10	143 0.8×	66 0.6×	40 0.5×	33 0.6×	35 1.2×	13	307
Shoubi Wang China	12	231 1.2×	87 0.8×	28 0.3×	107 1.8×	9 0.3×	19	388
Mathias Drach Austria	11	144 0.8×	141 1.3×	41 0.5×	26 0.4×	15 0.5×	18	344

Countries citing papers authored by Xiaoli Xie

Since Specialization

Citations

This map shows the geographic impact of Xiaoli Xie's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaoli Xie with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaoli Xie more than expected).

Fields of papers citing papers by Xiaoli Xie

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaoli Xie. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaoli Xie. The network helps show where Xiaoli Xie may publish in the future.

Co-authorship network of co-authors of Xiaoli Xie

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaoli Xie. A scholar is included among the top collaborators of Xiaoli Xie based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaoli Xie. Xiaoli Xie is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

Liu, Guihua, et al.. (2026). 4D Printing in Regenerative Medicine: Bio-Inspired Applications for Dynamic Tissue Repair. Journal of Functional Biomaterials. 17(2). 72–72.

Zhu, Yuejie, et al.. (2023). Bioinformatics-based design of a fusion vaccine with CTLA-4 variable region to combat Brucella. Brazilian Journal of Medical and Biological Research. 56. e12938–e12938. 1 indexed citations

Zhou, Chenhao, Jialei Weng, Chunxiao Liu, et al.. (2023). Disruption of SLFN11 Deficiency–Induced CCL2 Signaling and Macrophage M2 Polarization Potentiates Anti–PD-1 Therapy Efficacy in Hepatocellular Carcinoma. Gastroenterology. 164(7). 1261–1278. 76 indexed citations

Su, Quanping, et al.. (2023). B7-H7: A potential target for cancer immunotherapy. International Immunopharmacology. 121. 110403–110403. 3 indexed citations

Tang, Danting, et al.. (2022). Galectin Family Members: Emerging Novel Targets for Lymphoma Therapy?. Frontiers in Oncology. 12. 889034–889034. 12 indexed citations

Xie, Xiaoli, et al.. (2022). Establishment of a 7-microRNA prognostic signature and identification of hub target genes in colorectal carcinoma. Translational Cancer Research. 11(2). 367–381. 2 indexed citations

Chen, Jun, et al.. (2022). Hermansky-Pudlak syndrome type 2: A rare cause of severe periodontitis in adolescents—A case study. Frontiers in Pediatrics. 10. 914243–914243.

Chen, Jun, et al.. (2022). Low LINC02147 expression promotes the malignant progression of oral submucous fibrosis. BMC Oral Health. 22(1). 316–316. 5 indexed citations

Chen, Wenjian, Meng Gu, Bangjie Chen, et al.. (2021). The Prognostic Value and Mechanisms of TMEM16A in Human Cancer. Frontiers in Molecular Biosciences. 8. 542156–542156. 10 indexed citations

10.

Wang, Liying, Yanchun Quan, Yanxi Zhu, et al.. (2021). The regenerating protein 3A: a crucial molecular with dual roles in cancer. Molecular Biology Reports. 49(2). 1491–1500. 7 indexed citations

11.

Xie, Xiaoli, et al.. (2021). B7 Family Members in Lymphoma: Promising Novel Targets for Tumor Immunotherapy?. Frontiers in Oncology. 11. 647526–647526. 8 indexed citations

12.

Xie, Xiaoli, et al.. (2021). Fat mass and obesity‐associated protein regulates tumorigenesis of arecoline‐promoted human oral carcinoma. Cancer Medicine. 10(18). 6402–6415. 28 indexed citations

13.

Xia, Sheng, et al.. (2020). Role of HOXB7 in promoting gastric cancer progression and oxaliplatin (L-OHP) resistance.. PubMed. 13(6). 1381–1389. 4 indexed citations

14.

Yin, Jiawei, Xiaoli Xie, Yufu Ye, Lijuan Wang, & Fengyuan Che. (2019). BCL11A: a potential diagnostic biomarker and therapeutic target in human diseases. Bioscience Reports. 39(11). 46 indexed citations

15.

Zhang, Guanghui, et al.. (2019). Cross‑disease analysis identified novel common genes for both lung adenocarcinoma and lung squamous cell carcinoma. Oncology Letters. 18(4). 3463–3470. 2 indexed citations

16.

Che, Fengyuan, Xiaoli Xie, Long Wang, et al.. (2018). B7-H6 expression is induced by lipopolysaccharide and facilitates cancer invasion and metastasis in human gliomas. International Immunopharmacology. 59. 318–327. 32 indexed citations

17.

Che, Fengyuan, Jiawei Yin, Yanchun Quan, et al.. (2017). TLR4 interaction with LPS in glioma CD133+ cancer stem cells induces cell proliferation, resistance to chemotherapy and evasion from cytotoxic T lymphocyte-induced cytolysis. Oncotarget. 8(32). 53495–53507. 27 indexed citations

18.

Yang, Yeon-Mi, Xiaoli Xie, & Aoming Jin. (2016). Genetic polymorphisms in extracellular superoxide dismutase Leu53Leu, Arg213Gly, and Ala40Thr and susceptibility to type 2 diabetes mellitus. Genetics and Molecular Research. 15(4). 12 indexed citations

19.

Chen, Shuying, et al.. (2014). Association between leukocyte mitochondrial DNA content and risk of coronary heart disease: A case-control study. Atherosclerosis. 237(1). 220–226. 54 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact